SCHEMBL30135357

SCHEMBL30135357

CC(C)c1ncccc1-c1ncc(CO)c(NCc2ccc(-c3nc(C(F)(F)F)cn3C)cc2)n1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ USP1 O94782 20/20 0.61
▸ WDR48 Q8TAF3 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27087178 1.00 USP1 (0.61) USP1WDR48
SCHEMBL30135371 0.90 USP1 (0.63) USP1WDR48
SCHEMBL27087071 0.90 USP1 (0.63) USP1WDR48
SCHEMBL27086985 0.89 USP1 (0.60) USP1WDR48
SCHEMBL30135370 0.89 USP1 (0.60) USP1WDR48
SCHEMBL31423557 0.87 USP1 (0.61) USP1WDR48
SCHEMBL31293589 0.86 USP1 (0.60) USP1
SCHEMBL27086993 0.85 USP1 (0.57) USP1
SCHEMBL30135372 0.85 USP1 (0.57) USP1
SCHEMBL30135298 0.84 USP1 (0.58) USP1WDR48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319758-A1 INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) Forma Therapeutics, Inc. (US) 2024-02-14 — — EP disclosed
WO-2022216820-A1 INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) FORMA THERAPEUTICS, INC. (US) 2022-10-13 — — WO disclosed
Send feedback